Erratum to: The Outcomes of First Reoperation for Locoregionally Recurrent/Persistent Papillary Thyroid Carcinoma in Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation (Journal of Clinical Endocrinology and Metabolism (2011) 96:7 (2049-2056) DOI: 10.1210/jc.2010-2298);The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 7, 2011, Pages 2049-2056

  Yim, Ji Hye ^a   Kim, Won Bae ^a   Kim, Eui Young ^a   Kim, Won Gu ^a   Kim, Tae Yong ^a   Ryu, Jin Sook ^b   Gong, Gyungyub ^b   Hong, Suck Joon ^a   Shong, Young Kee ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CERVICAL LYMPH NODE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE FREE SURVIVAL; RECURRENT CANCER; REOPERATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

EID: 79960087723     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/clinem/dgad573     Document Type: Erratum

References (16)

1. Grebe SK, Hay ID 1996 Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 5:43-63 (Pubitemid 26047382)
2. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428 (Pubitemid 24345593)
3. Palme CE, Waseem Z, Raza SN, Eski S, Walfish P, Freeman JL 2004 Management and outcome of recurrent well-differentiated thyroid carcinoma. Arch Otolaryngol Head Neck Surg 130:819-824 (Pubitemid 38915967)
4. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamou E, Gardet P, Caillou B, Travagli JP, Parmentier C 1985 Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55:794-804 (Pubitemid 15173518)
5. Gibelli B, Tredici P, De Cicco C, Bodei L, Sandri MT, Renne G, Bruschini R, Tradati N 2005 Preoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin. Acta Otorhinolaryngol Ital 25:94-99
6. Maxon HR, Thomas SR, Hertzberg VS, Kereiakes JG, Chen IW, Sperling MI, Saenger EL 1983 Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer.NEngl J Med 309:937-941
7. Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR 2002 Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol 178:699-704 (Pubitemid 34178153)
8. Lim CY, Yun JS, Lee J, Nam KH, Chung WY, Park CS 2007 Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma. Thyroid 17:347-350 (Pubitemid 46776139)
9. Monchik JM, Donatini G, Iannuccilli J, Dupuy DE 2006 Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244:296-304 (Pubitemid 44305546)
10. Cooper DS, Doherty GM, Haugen BR, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
11. Schuff KG, Weber SM, Givi B, Samuels MH, Andersen PE, Cohen JI 2008 Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 118:768-775 (Pubitemid 351631273)
12. Al-Saif O, Farrar WB, Bloomston M, Porter K, Ringel MD, Kloos RT 2010 Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab 95:2187-2194
13. Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, Ryu JS, Gong G, Hong SJ, Shong YK 2008 Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93:4683-4689
14. Coburn M, Teates D, Wanebo HJ 1994 Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131). Ann Surg 219:587-593; discussion 593-595
15. Maxon 3rd HR, Englaro EE, Thomas SR, Hertzberg VS, Hinnefeld JD, Chen LS, Smith H, Cummings D, Aden MD 1992 Radioiodine-131 therapy for well-differentiated thyroid cancer-a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 33:1132-1136
16. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR 2003 Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126